Effect of intravitreal bevacizumab (IVB) in treating macular edema secondary to branch retinal vein occlusion (BRVO).
Wong
Ian
I
Koo
Simon
S
Chan
Clement
C
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology*; D012170:Retinal Vein Occlusion / Q000150:complications*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab